©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 113476
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113476
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113476
Table 1 Basic information of patients, n (%)/mean ± SD
| Control group | Adenoma group | t/χ2 | P value | |
| Number | 103 | 315 | ||
| Gender | ||||
| Male | 55 (53.4) | 202 (64.1) | 3.773 | 0.052 |
| Female | 48 (46.6) | 113 (35.9) | ||
| Age (years) | 52.70 ± 14.35 | 54.97 ± 12.74 | -1.525 | 0.128 |
| History of diabetes | 16 (15.5) | 97 (30.8) | 9.163 | 0.002 |
| History of hypertension | 19 (18.4) | 66 (21.0) | 0.301 | 0.583 |
| Hyperuricemia | 1 (1.0) | 6 (1.9) | 0.040 | 0.842 |
| Hyperlipidemia | 5 (4.9) | 24 (7.6) | 0.919 | 0.338 |
- Citation: Gui SY, Tang RX, Huang X, Yang GQ, Yang J. Association between type 2 diabetes mellitus and colorectal adenoma: A retrospective study with insights into Wnt/β-Catenin/TCF7L2 pathway activation. World J Gastrointest Surg 2026; 18(2): 113476
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/113476.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.113476